Search

Your search keyword '"P. G. Chiriacò"' showing total 4 results
Start Over Author "P. G. Chiriacò"
4 results on '"P. G. Chiriacò"'

2. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy

Author

M. G. Marazzi, G. Sabatino, G. Ferraris, Rita Consolini, M. Ruggeri, C. Salvatore, Alberto Vierucci, D. De Mattia, R. Pinzani, R. Lipreri, S. Catania, S. Riva, S. Boni, C. Gotta, C. Cancrini, C. Fundarò, A. Antonellini, E. Massironi, R. Tornaghi, Orazio Genovese, L. Anastasio, Anna Maccabruni, G. L. Forni, P. Crispino, Gianfranco Anzidei, P. Zizzadoro, G. Castelli Gattinara, M. De Martino, C. Giaquinto, S. Bernardi, G. Gambaretto, Luisa Galli, P. Osimani, L Tarallo, C. Dessì, Massimo Masi, Antonio Mazza, M. Sticca, S. Farina, A. De Maria, A. Meo, Clara Gabiano, P. G. Chiriacò, Alfredo Guarino, A. Romano, C. Scolfaro, Monica Cellini, Claudio Pignata, A. Miniaci, Marcello Lanari, M. De Luca, G. Dell'Erba, E. Pontali, Marzia Duse, S. de Carlis, S. Dalla Vecchia, F. Salvini, G. Benaglia, R. Berrino, M. Dedoni, C. Pintor, Gian Vincenzo Zuccotti, Francesca Fioredda, C. Magnani, Paola Marchisio, C. Rendeli, L. Tasso, M. Zappa, A. Lodato, L. Battisti, M. Stegagno, T. Cecchi, C. Riva, E. Uberti, C. Timpano, Osvalda Rampon, Désirée Caselli, D. Loriano, E. Palomba, G. Palla, Anna Plebani, A. Pellegatta, Pier-Angelo Tovo, A. Bucceri, E. Ruga, E. Bresciani, and F. Baldi

Subjects
Pregnancy, Pediatrics, medicine.medical_specialty, business.industry, Immunology, Disease progression, Human immunodeficiency virus (HIV), medicine.disease, medicine.disease_cause, Rapid disease progression, Zidovudine, Infectious Diseases, Perinatal infection, medicine, Immunology and Allergy, business, medicine.drug
Published
1999
Full Text
View/download PDF

3. Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in Human Immunodeficiency Virus-1-seropositive patients

Author

A. De Donno, S. Minniti, M. De Simone, Sabrina Bacilieri, Filippo Ansaldi, Giovanni Gabutti, Paolo Durando, S. Cataldini, Roberto Gasparini, M. Quattrocchi, P. G. Chiriacò, Laura Sticchi, Marcello Guido, Gabutti, G, Guido, Marcello, Durando, P, DE DONNO, Maria Antonella, Quattrocchi, Manuela, Bacilieri, S, Ansaldi, F, Cataldini, S, Chirac, Tg, DE SIMONE, M, Minniti, S, Sticchi, L, and AND GASPARINI, R.

Subjects
CD4-Positive T-Lymphocytes, Male, Time Factors, Human Immunodeficiency virus-1 RNA, MF59, Polysorbates, 030204 cardiovascular system & hematology, Antibodies, Viral, Biochemistry, CD4+, 0302 clinical medicine, HIV Seropositivity, Medicine, biology, Human immunodeficiency virus, Influenza vaccine, Immunogenicity, General Medicine, Middle Aged, Viral Load, Vaccination, Influenza Vaccines, 030220 oncology & carcinogenesis, RNA, Viral, Female, CD4+ T-lymphocytes, Human immunodeficiency virus-1 RNA, Safety, Antibody, Viral load, T-lynphocyte, Adult, Risk, Squalene, Adolescent, 03 medical and health sciences, Adjuvants, Immunologic, Humans, Viremia, Seroconversion, Adverse effect, Aged, business.industry, Human Immunodeficiency viru, Biochemistry (medical), Cell Biology, Virology, CD4 Lymphocyte Count, Immunology, HIV-1, biology.protein, business
Abstract

In this study of influenza vaccination, 37 human immunodeficiency virus (HIV)-1-seropositive patients were randomized to receive either a vaccine with a conventional subunit or one adjuvanted with MF59. Blood samples were collected at the time of vaccination, and then 30 and 180 days later, to evaluate immunogenicity, CD4+ T-lymphocyte count and HIV-1 RNA levels. Seroconversion rates against the three viral strains included in the vaccine ranged between 44% and 72% and 53% and 68% for the adjuvanted vaccine and the subunit vaccine, respectively. Other criteria of the European Medicines Evaluation Agency were also met. Vaccination was not associated with serious adverse events. Local and systemic effects were mild and of short duration. CD4+ T-lymphocyte counts and viraemia levels were not negatively affected by vaccination. These results confirmed the safety and immunogenicity of these currently available vaccines in HIV-1-seropositive patients, thus supporting the recommendation for influenza immunization in this high-risk category.

Published
2005

4. Long-term nonprogressors among children with perinatal HIV-1 infection

Author

P. A. Tovo, M. de Martino, C. Gabiano, L. Galli, G. Ferraris, P. Marchisio, C. Giaquinto, S. Tulisso, G. V. Zuccotti, A. Loy, A. Vierucci, G. Castelli Gattinara, D. Caselli, A. Plebani, C. fundarò, P. Dallacasa, M. Belloni, P. L. Mazzoni, C. Timpano, M. Ruggeri, R. Consolini, G. L. Forni, G. Benaglia, M. G. Marazzi, M. Cellini, A. Mazza, C. Pignata, V. Portelli, D. De Mattia, A. Corrias, C. Gotta, T. Bezzi, G. Caramia, A. Antonellini, E. Anastasio, G. gambaretto, C. Salvatore, L. Battisti, M. Sticca, M. Masi, P. Ibba, S. Bionda, U. De Sarntis, F. Baldi, C. Magnani, A. Pellegatta, R. Berrino, C. Dessì, L. Tasso, L. A. Magni, L. Tarallo, C. Ajassa, U. Tondo, P. G. Chiriacò, I. Contardi, A. Meo, F. Di Gregorio, P. Paolucci, L. Esposito, E. Boeri, D. Tommasi, GUARINO, ALFREDO, Tovo, P. A., de Martino, M., Gabiano, C., Galli, L., Ferraris, G., Marchisio, P., Giaquinto, C., Tulisso, S., Zuccotti, G. V., Loy, A., Vierucci, A., Castelli Gattinara, G., Caselli, D., Plebani, A., Fundarò, C., Dallacasa, P., Belloni, M., Mazzoni, P. L., Timpano, C., Ruggeri, M., Consolini, R., Forni, G. L., Benaglia, G., Marazzi, M. G., Cellini, M., Mazza, A., Pignata, C., Portelli, V., De Mattia, D., Corrias, A., Guarino, Alfredo, Gotta, C., Bezzi, T., Caramia, G., Antonellini, A., Anastasio, E., Gambaretto, G., Salvatore, C., Battisti, L., Sticca, M., Masi, M., Ibba, P., Bionda, S., De Sarntis, U., Baldi, F., Magnani, C., Pellegatta, A., Berrino, R., Dessì, C., Tasso, L., Magni, L. A., Tarallo, L., Ajassa, C., Tondo, U., Chiriacò, P. G., Contardi, I., Meo, A., Di Gregorio, F., Paolucci, P., Esposito, L., Boeri, E., and Tommasi, D.

Published
1997

Catalog

Books, media, physical & digital resources
See catalog results